Neuroreport · 2025
Circadian disruption exacerbates cognitive impairment via an intense neuroinflammatory reaction and alpha-synuclein deposition in a Parkinson's disease mouse model.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deng Rong, Liu Chang, Jin Hong, Cao Yulan, Wang Lanxiang, Zhang Yuting, Wang Fen, Chen Jing
Аннотация
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative disorder marked by motor symptoms and nonmotor complications, notably cognitive impairment, which severely impairs patients' quality of life. While circadian disruption (CD) correlates with cognitive decline in PD, it remains unclear whether CD is merely secondary to motor symptoms or directly contributes to cognitive dysfunction. The objective of this study was to investigate whether chronic CD exacerbates cognitive decline in PD.
BASIC METHODS: Male mice were subjected to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD and divided into groups with or without chronic exposure to CD. Observational assessments of cognitive deficits were performed alongside analytical measurements of tyrosine hydroxylase (TH) content in the striatum, α-synuclein deposition levels, and neuroinflammatory responses in the hippocampus.
MAIN RESULTS: MPTP-treated mice exposed to CD exhibited significantly more severe cognitive deficits compared to MPTP-treated controls without CD. These deficits correlated with pronounced reductions in striatal TH content, elevated α-synuclein accumulation, and intensified neuroinflammatory activity in the hippocampal region. The observed changes demonstrated CD-induced exacerbation of pathological hallmarks.
CONCLUSIONS: Chronic CD directly aggravates MPTP-driven neuroinflammatory processes and α-synuclein pathology in the hippocampus, leading to accelerated cognitive deterioration. These findings substantiate CD as an environmental risk factor for cognitive decline in PD progression, independent of motor symptom sequelae. The study provides mechanistic insights into CD's contributory role in PD-related cognitive impairment.
BASIC METHODS: Male mice were subjected to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD and divided into groups with or without chronic exposure to CD. Observational assessments of cognitive deficits were performed alongside analytical measurements of tyrosine hydroxylase (TH) content in the striatum, α-synuclein deposition levels, and neuroinflammatory responses in the hippocampus.
MAIN RESULTS: MPTP-treated mice exposed to CD exhibited significantly more severe cognitive deficits compared to MPTP-treated controls without CD. These deficits correlated with pronounced reductions in striatal TH content, elevated α-synuclein accumulation, and intensified neuroinflammatory activity in the hippocampal region. The observed changes demonstrated CD-induced exacerbation of pathological hallmarks.
CONCLUSIONS: Chronic CD directly aggravates MPTP-driven neuroinflammatory processes and α-synuclein pathology in the hippocampus, leading to accelerated cognitive deterioration. These findings substantiate CD as an environmental risk factor for cognitive decline in PD progression, independent of motor symptom sequelae. The study provides mechanistic insights into CD's contributory role in PD-related cognitive impairment.